$2.57 billion

scientist, to serve as the director of the company’s research and development projects.

The company ranked No 1 worldwide in terms of its market share of gene tumor diagnostic products for three consecutive years, after it developed a research team led by a medical PhD Zhu Guanshan.

Haicang has organized a raft of biomedicine summits, forums and innovation and entrepreneurship competitions to increase the influence of its biomedicine industry.

Last year, the district invited 19 foreign senior experts from nine countries including the United States, Russia, Japan and Italy, via the national Recruitment Program of Global Experts, to visit local biomedical companies and startups to provide technological guidance.

Haicang invested nearly 1 billion yuan to build a biomedicine industry zone covering an area of 10 million square meters.

The zone is home to 30 research and public service centers, which provide about 90,000 services. It has more than 18,000 staff members, including 75 leading experts and 3,000 workers with senior technical titles.

The district also works with local commercial banks and the Xiamen Cross-Straits Equity Exchange Center to organize matchmaking events for biomedical companies, as well as project road shows and financial training courses.

The combined estimated value of its 97 local biomedical companies has almost reached 70 billion yuan.